Howland Capital Management LLC Has $230,000 Stake in The Clorox Company (NYSE:CLX)

Howland Capital Management LLC trimmed its stake in The Clorox Company (NYSE:CLXFree Report) by 11.8% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,500 shares of the company’s stock after selling 200 shares during the period. Howland Capital Management LLC’s holdings in Clorox were worth $230,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of CLX. Fortitude Family Office LLC acquired a new stake in Clorox during the 4th quarter worth about $29,000. Venturi Wealth Management LLC grew its holdings in Clorox by 308.5% during the 1st quarter. Venturi Wealth Management LLC now owns 192 shares of the company’s stock worth $29,000 after acquiring an additional 145 shares during the period. Northwest Financial Advisors acquired a new stake in Clorox during the 4th quarter worth about $29,000. Core Wealth Advisors Inc. acquired a new stake in Clorox during the 4th quarter worth about $29,000. Finally, First United Bank & Trust acquired a new stake in Clorox during the 4th quarter worth about $31,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Performance

Shares of Clorox stock traded up $1.70 during mid-day trading on Friday, hitting $136.54. 46,142 shares of the stock were exchanged, compared to its average volume of 1,239,051. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $169.14. The company has a 50-day simple moving average of $134.78 and a 200 day simple moving average of $143.23. The company has a debt-to-equity ratio of 9.73, a quick ratio of 0.53 and a current ratio of 0.90. The company has a market capitalization of $16.96 billion, a P/E ratio of 69.87, a P/E/G ratio of 2.00 and a beta of 0.39.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, beating analysts’ consensus estimates of $1.33 by $0.38. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The firm had revenue of $1.81 billion during the quarter, compared to analyst estimates of $1.87 billion. During the same period in the previous year, the business earned $1.51 EPS. The business’s revenue for the quarter was down 5.3% on a year-over-year basis. Sell-side analysts anticipate that The Clorox Company will post 5.91 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the company. Citigroup decreased their price target on Clorox from $150.00 to $145.00 and set a “neutral” rating for the company in a report on Wednesday. JPMorgan Chase & Co. reduced their target price on Clorox from $159.00 to $158.00 and set a “neutral” rating for the company in a research note on Wednesday, May 1st. DA Davidson restated a “neutral” rating and issued a $162.00 target price on shares of Clorox in a research note on Wednesday, April 17th. Morgan Stanley restated an “equal weight” rating and issued a $160.00 target price on shares of Clorox in a research note on Tuesday, March 26th. Finally, Barclays reduced their target price on Clorox from $136.00 to $132.00 and set an “underweight” rating for the company in a research note on Thursday, May 2nd. Five research analysts have rated the stock with a sell rating and fourteen have issued a hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $144.67.

Check Out Our Latest Stock Analysis on CLX

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Further Reading

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.